GLP-1 & MetabolicRefrigerated Stability: 45 Days

Retatrutide Peptide Dosage & Reconstitution Calculator

Retatrutide (LY3437943), often referred to informally in research as reta peptide, is an experimental tri-agonist peptide developed to simultaneously activate GIP, GLP-1, and glucagon receptors for metabolic expenditure research.

Also referenced as: Triple G, GIP/GLP-1/Glucagon

Live Precision Calculator

Retatrutide Stoichiometry

1. Peptide Powder Quantity in Vial (mg)e.g. 5 mg

2. Bacteriostatic Water Added (mL)e.g. 2 mL

3. Target Desired Dose

mcg

4. Syringe Barrel Type

Optional: Vial Purchase Price ($) for Cost-per-Dose breakdown

Required Syringe Draw

20IU (Units)

Liquid Draw Volume: 0.2 mL

Concentration5 mg/mL(5000 mcg/mL)

Doses per Vial5 doses(1000 mcg/dose)

Live Visual Gauge

U-100 Insulin Syringe (1 mL / 100 Units)

20 IU (Units)

0.200 mL liquid

Capacity: 1 mLTarget fill: 20.0% of barrel

Retatrutide Reconstitution Procedure

Use sterile bacteriostatic water. Do not freeze once reconstituted.

Storage & Handling:

Refrigerate at 2–8°C away from direct sunlight.

Retatrutide Frequently Asked Questions

What is reta peptide?

Reta peptide is a common informal research shorthand for Retatrutide, a triple receptor agonist targeting GIP, GLP-1, and glucagon pathways.

How is concentration expressed for Retatrutide?

A 10mg vial reconstituted with 2mL BAC water yields 5mg/mL (5,000 mcg/mL).

Retatrutide Quick Reference

Category:GLP-1 & Metabolic

Molecular Weight:4731.3 g/mol

Typical Vial Sizes:5mg, 10mg, 15mg

Default Dose:1000 mcg

Shelf Stability:45 Days (2-8°C)

Related GLP-1 & Metabolic Peptides

Semaglutide

GLP-1 receptor agonist research reference for metabolic and glucose homeostasis studies.

Tirzepatide

Dual GIP and GLP-1 receptor agonist reference peptide.

Cagrilintide

Long-acting acylated amylin analogue studied for satiety pathways.

Looking for other peptides?Browse the full 150+ Peptide Library Directory or return to the main General Calculator Engine.